Vaughan Nelson Investment Management’s Integra LifeSciences IART Stock Holding History

Vaughan Nelson Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-948,212	Closed	-$44.6M	–	191
2020 Q2	$44.6M	Sell	948,212 -203,120	-18%	-$9.98M	0.64%	51
2020 Q1	$51.4M	Buy	1,151,332 +298,015	+35%	+$15.6M	0.88%	36
2019 Q4	$49.7M	Sell	853,317 -9,363	-1%	-$557K	0.62%	60
2019 Q3	$51.8M	Buy	862,680 +12,728	+1%	+$758K	0.69%	50
2019 Q2	$47.5M	Sell	849,952 -260,225	-23%	-$13.4M	0.63%	53
2019 Q1	$61.9M	Buy	1,110,177 +230,010	+26%	+$11.7M	0.83%	35
2018 Q4	$39.7M	Buy	880,167 +511,085	+138%	+$28M	0.57%	74
2018 Q3	$24.3M	Buy	369,082 +14,875	+4%	+$924K	0.28%	144
2018 Q2	$22.8M	Sell	354,207 -189,800	-35%	-$11.8M	0.27%	142
2018 Q1	$30.1M	Sell	544,007 -32,093	-6%	-$1.68M	0.37%	131
2017 Q4	$27.6M	Sell	576,100 -319,875	-36%	-$15.7M	0.32%	144
2017 Q3	$45.2M	Sell	895,975 -6,500	-0.7%	-$334K	0.54%	82
2017 Q2	$49.2M	Buy	902,475 +22,900	+3%	+$1.09M	0.59%	73
2017 Q1	$37.1M	Buy	879,575 +254,825	+41%	+$10.9M	0.44%	113
2016 Q4	$26.8M	Buy	624,750 +42,650	+7%	+$1.73M	0.32%	135
2016 Q3	$24M	Sell	582,100 -647,100	-53%	-$27.1M	0.28%	138
2016 Q2	$49M	Buy	1,229,200 +22,250	+2%	+$801K	0.62%	74
2016 Q1	$40.7M	Sell	1,206,950 -311,250	-21%	-$9.69M	0.51%	89
2015 Q4	$51.5M	Sell	1,518,200 -1,231,900	-45%	-$38.5M	0.66%	68
2015 Q3	$81.9M	Sell	2,750,100 -168,419	-6%	-$5.27M	1.17%	15
2015 Q2	$80.4M	Buy	2,918,519 +34,679	+1%	+$924K	1.13%	24
2015 Q1	$72.7M	Sell	2,883,840 -540,670	-16%	-$12.8M	1.11%	30
2014 Q4	$75.9M	Sell	3,424,510 -34,312	-1%	-$696K	1.11%	29
2014 Q3	$70.2M	Sell	3,458,822 -31,315	-0.9%	-$623K	1.05%	30
2014 Q2	$67.1M	Buy	3,490,137 +165,443	+5%	+$3.08M	0.95%	37
2014 Q1	$62.5M	Sell	3,324,694 -117,492	-3%	-$2.27M	0.94%	42
2013 Q4	$67.1M	Buy	3,442,186 +165,014	+5%	+$3.03M	1.05%	35
2013 Q3	$53.9M	Buy	3,277,172 +158,104	+5%	+$2.54M	0.91%	46
2013 Q2	$46.7M	Buy	+3,119,068	New	+$45.7M	0.88%	44

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Vaughan Nelson Investment Management's IART Position: Q3 2020 in Review

Vaughan Nelson Investment Management sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 948,212 shares — an estimated $44.6M sold.

Vaughan Nelson Investment Management first reported a position in IART in Q2 2013 and held it in 29 quarters. The position peaked at $81.9M in Q3 2015. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

Vaughan Nelson Investment Management reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
Vaughan Nelson Investment Management sold 948,212 Integra LifeSciences shares in Q3 2020, an estimated $44.6M.
Vaughan Nelson Investment Management first reported a position in Integra LifeSciences in Q2 2013 and held it in 29 quarters.
Vaughan Nelson Investment Management's Integra LifeSciences position peaked at $81.9M in Q3 2015.
237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on Vaughan Nelson Investment Management's 13F filing for Q3 2020, filed 9 Nov 2020.